Clinical Trials Directory

Trials / Completed

CompletedNCT04377035

The Role of Ultrasound in COVID-19

The ECHOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart and Lung by Ultrasound

Status
Completed
Phase
Study type
Observational
Enrollment
305 (actual)
Sponsor
University Hospital, Gentofte, Copenhagen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if echocardiography - both conventional and advanced - can be used to predict which patients will develop acute respiratory distress syndrome (ARDS) or other short-term acute complications, especially focusing on cardiovascular outcomes. In addition, using a novel technique of lung ultrasound (LUS), The investigators aim to analyze specific LUS-findings, and associate them with short-term prognosis and development of ARDS and long-term cardiovascular morbidity and mortality. In all patients included, The investigators aim to examine long-term complications at timepoints: 2, 5 and 10 years of follow-up and examine if echocardiography - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection

Conditions

Timeline

Start date
2020-03-31
Primary completion
2021-03-01
Completion
2021-03-01
First posted
2020-05-06
Last updated
2023-06-26

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04377035. Inclusion in this directory is not an endorsement.